Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Varex Imaging (VREX) Receivables (2016 - 2026)

Varex Imaging (VREX) has disclosed Receivables for 11 consecutive years, with $146.5 million as the latest value for Q1 2026.

  • On a quarterly basis, Receivables rose 6.08% to $146.5 million in Q1 2026 year-over-year; TTM through Jan 2026 was $146.5 million, a 6.08% increase, with the full-year FY2025 number at $156.6 million, down 0.7% from a year prior.
  • Receivables was $146.5 million for Q1 2026 at Varex Imaging, down from $156.6 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $198.7 million in Q3 2022 to a low of $137.0 million in Q3 2025.
  • A 5-year average of $161.3 million and a median of $157.2 million in 2024 define the central range for Receivables.
  • Peak YoY movement for Receivables: increased 20.83% in 2022, then fell 23.84% in 2023.
  • Varex Imaging's Receivables stood at $183.3 million in 2022, then dropped by 23.84% to $139.6 million in 2023, then increased by 12.97% to $157.7 million in 2024, then fell by 0.7% to $156.6 million in 2025, then decreased by 6.45% to $146.5 million in 2026.
  • Per Business Quant, the three most recent readings for VREX's Receivables are $146.5 million (Q1 2026), $156.6 million (Q4 2025), and $137.0 million (Q3 2025).